Cost Utility Analysis of Infliximab for the Treatment of Severe Rheumatoid Arthritis in Thailand
Abstract
Authors
D. Tangwongsiri J. Leartsakulpanitch
D. Tangwongsiri J. Leartsakulpanitch
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now